Cytek Biosciences, Inc. (CTKB) Misses Q2 EPS by 1c

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported Q2 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $40.2 million versus the consensus estimate of $39.63 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MP Materials seen largely insulated after China export-control move
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating